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Objectives . This report summarizes our experience with the use
of occluding spring coils to close the small patent ductus arlerio-
sus.
Background. Several patent ductus arteriosus occluders (most
notably the Ruslikind device) have been developed and studied .
Occluding spring coils have been used to close abnormal vessels
and vascular connections. We previously reported the use of
occluding spring coils to close the small patent ductus arteriosus in
a small group of patients . This report describes our series of
patients having patent ductus arteriosus closure with occluding
spring coils.
Methods . Between June 1990 and June 1993, 30 patients
underwent cardiac catheterization to have patent ducats arterio-
sus closure by occluding spring coils . Selection criteria were age
>6 months and narrowest patent ductus arteriosus internal
dimension :53.0 mm by color flow imaging. Definitive selection
was based on review of aortograms performed at catheterizatior
A 5.2F coronary catheter was used to deliver one or two standard
occluding spring coils . A loop was delivered in the main pulmo-
nary artery, and the remainder of the coil was delivered across the
patent ductus arteriosus and into the aortic diverticulum . Patent
In 1971 Porstmann et al . (1) described the first nonsurgical
closure of a patent ductus arteriosus with an Ivalon plug by
way of an 18F arterial conduit . More recently, the RLshkind
double-umbrella occlusion system has been extensively
evaluated (2-11) . With this system, the patent ductus arte-
riosus is usually occluded through either an SF or an I IF
delivery system . Other devices include the "buttoned"
device, which uses a 7F delivery system (12), and the
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duMs arleriosus closure was confirmed by aortography or color
flow imaging, or both . Follow-up after coil placement occurred at
6 weeks and 6 months and included two-view chest radiography,
echocardiography and color flow imaging .
Results . Of the 30 patients, 29 had successful implantation by
one (27 patients) or two (2 patients) occluding spring coils . Of
these 29 patients, 19 had a clinically apparent and 10 had a silent
patent ductus arteriosus . Average ductus minimal internal dimen-
sion was 1 .7 mm (range 1 .0 to3.0). Complete closure of the ductus
was confirmed in 27 patients by autography or co lor flow imaging
or both (in 24 within 4 h, in 2 after 6 weeks and in 1 after 6
months). Six weeks after implantation, two patients had a tiny
residual patent ductus arteriosus noted on color flow imaging . One
patient did not have successful implantation . This patient had a
3.2-mm ductus, and two coils migrated to the distal left pulmo-
nary artery and could not be retrieved . There were no deaths or
any significant complications noted during early or late follow-up
in these patients .
Conclusions. Occluding spring coils may have additional ap-
plication in closing the small patent ductus arteriosus .
(.1 Ann Coll Cardiol 1994,23:759-65)
Botallooccluder, which requires at least a 10F delivery
system (13) .
Because of their relatively large size, these occlusion
systems have difficulty accommodating the very small patent
ductus arteriosus . Some authorities have described compli-
cated techniques to prepare the very small ductus for closure
with the Rashkind system (14,15) . Other investigators have
argued that the very small or "silent" patent ductus arte-
riosus may not require closure (16) .
This controversy re-
mains unresolved .
In addition to the issues related to the size of delivery
systems, percutaneous patent ductus arteriosus occlusion
has been problematic because of residual ductus patency
after device implantation
. Relatively high rates of immediate
postprocedure residual leaks have been observed . More-
over, even years later in many patients, the device-treated
patent ductus arteriosus has residual flow (7,8,10,11) . In
some patients, second Rashkind devices have been placed,
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resulting in complete occlusion. However, small residual
leaks raise the same practical closure issues as the very small
patent ductus arteriosus and may not be amenable to ciosure
with a second device.
We (17) have previously reported patent ductus arterio-
sus closure with occluding spring coils in a small group of
patients . Coil occlusion is performed through a smaller
delivery system and is a simpler procedure than any of the
other methods. The use of coils has application to the small
native patent ductus arteriosus and may have application to
the residual patent ductus arteriosus (after implantation of a
device or after surgical ligation)
. Moreover, we have suc-
cessfully used coil embolization to occlude some clinically
apparent and hemodynamically significant PDA . This report
discusses our experience with percutaneous closure of the
small patent ductus arteriosus by occluding spring coils .
Methods
Fa&ags. Between June 1990 and June 1993, 30 patients
with a small patent ductus arteriosus diagnosed by physical
examination, two-dimensional echocardiography and color
flow imaging studies underwent cardiac catheterizatkon to
have patent ductus arteriosus closure by occluding spring
coils. Whenever possible, these procedures were scheduled
as outpatient catheterizations. All patients were >6 months
of age, and no patient had an associated lesion requiring
surgical correction or palliation . These patients were not con-
secutive because patients with a minimal internal patent ductus
arteriosus dimension >3 .0 mm (by color flow imaging) were
offered surgical closure or, if it was requested and deemed
clinically appropriate, a delay in treatment until the Rashkind
system became available . All families provided informed con-
sent in accordance with institutional policies. The patients
in age from 7 months to 12 years (average 3 .5 years).
Their weight ranged from 8 .1 to 42.2 kg (average 15.9) .
Eighteen patients had an isolated patent ductus arteriosus,
and 12 had associated conditions . Five patients with associ-
ated conditions required interventional catheter treatment
(one patient had valvuloplasty for pulmonary valve stenosis ;
W patients had coil occlusion of an aortopulmonary col-
lateral artery). One patient with dilated cardiomyopathy had
multiple ventricular biopsies performed . The other four
patients had mild aortic insufficiency (one patient), mild
pulmonary valve stenosis (three patients), partial anomalous
pulmonary venous connection (one vein in one patient) and
frequent premature ventricular contractions (one patient) .
r mW delivery system. The occluder and delivery
system ate simple and commercially available . Occluding
spring coils (Cook Incorporated) were used as occiuders .
One or two of the several available sizes (MWCE-38-4-3,
MWCE-38-5-5, MWCE-38-5-8, MWCE-38-8-5) were used .
The diameter of the extended coil in each device is 0 .038 in
(0.096 cm). The length of the extended coil is 4, 5 or 8 cm .
The diameter of the coil is 3, 5 or 8 mm . The coils are made
of surgical stainless steel and have thrombogenic Dacron
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strands attached to them . The delivery system is a 5.217
Judkins Right 3 .5 coronary catheter (Cordis Corp .) that can
pass through a standard 5F intravascular sheath . The embo-
lus is pushed through the catheter with a standard 0 .038-in .
straight guide wire .
Pm-edure. Patients received ketamine sedation at appro-
priate dosage for weight, and 5F sheaths were placed in the
femoral vein and artery . Heparin (100 U/kg body weight)
was administered . Routine right heart pressure and oxygen
saturation levels were measured . A SF pigtail catheter was
placed in the descending thoracic aorta adjacent to the
takeoff of the patent ductus arteriosus . An aortic cineangio-
gram was performed in the anterior and 90' lateral projec-
tions. Morphologic characteristics of the patent ductus arte-
riosus were determined . The narrowest internal dimension
of the ductus was measured by use of magnification correc-
tion with reference comparison to known angiographic cath-
eter dimension. After review of the cineangiogram, the
decision to proceed with coil occlusion was made . Cefazolin
(40 mg/kg) was administered intravenously . The pigtail cath-
eter was removed. A 5.2F Judki Right 3 .5 coronary
catheter was placed in the descendi thoracic aorta . With
the use of a 0 .035-in . (0.088 cm) st -~~;ht guide wire, the
patent ductus arteriosus was crossi .1 ifth the Judkins cath-
eter. The wire was removed, and the pressure and oxygen
saturation in the main pulmonary artery were measured to
confirm catheter tip location . An occluding spring coil was
selected such that the minimal internal dimension of the
patent ductus arteriosus was s5017b of the coil diameter . The
coil was loaded into the Judkins catheter using the stiff end
of a 0 .038-in. straight guide wire . After loading, the 0 .038-in .
straight guide wire was reversed, and the soft tip of the wire
was used to push the coil through the catheter lumen . The
delivery was monitored by lateral fluoroscopy . The coil was
pushed until a full loop of the device was extruded from the
catheter into the main pulmonary artery . By using the lateral
aortogram as a reference and the tracheal air shadow as a
landmark, the delivery catheter was subsequently pulled
back until the extruded loop of coil was observed being
resisted by the pulmonary end of the patent ductus arterio-
sus. After this, the delivery catheter was pulled across the
ductus into the aorta while the coil was pushed out into the
ductus and the aorta. The delivery was completed while
continuously maintaining a complete loop of the coil in the
main pulmonary artery adjacent to the patent ductus arteri-
osus orifice . As the catheter was pulled back and the coil
pushed from it, the ductus and aortic portions of the coil
straightened . With release from the delivery catheter, the
coil formed at least two full loops within the aortic divertic-
ulum or along the side wall of the aorta (Fig . 1) . The delivery
of the coil was best performed by a single operator. Delivery
of two coils used similar techniques . The patent ductus
arteriosus was crossed by two coronary catheters, one from
the arterial end and the second from the pulmonary end . The
first coil was delivered by the single-coil method . The second
coil was delivered by using the loops of the first coil as
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Figure 1 . Lateral cineangio-
graphic frames demonstrate deliv-
ery of a coil to close the patent
ductus arteriosus in Patient 9 .
A, Lateral aortic cineangiogram
shows a very small patent ductus
arteriosus (type E) with a minimal
internal dimension `I mm .
13, Wire guides the passage of a
5.2F Judkins coronary catheter
from the aorta across the ductus
into the main pulmonary artery
.
C, Judkins catheter tip in the main
pulmonary artery with one loop of
embolus delivered . D, Delivery of
the coil in the ductus and the
aortic end of the ductus with the
loop in the main pulmonary ar-
tery . E, Release of the coil results
in the straight potion of the em-
bolus in the patent ductus arteri-
osus and loop(s) forming in the
aorta. F, Lateral aortic cine-
angiogram 10 min after delivery of
the coil shows complete occlusion
of the patent ductus arteriosus
.
landmarks. One loop was delivered in the aortic diverticu-
lum. The catheter was pulled back across the patent ductus
arteriosus into the main pulmonary artery while the second
coil was pushed into the ductus and the main pulmonary
artery. The delivery catheter or catheters were removed and
a 5F pigtail catheter was placed in the thoracic aorta
. After
a delay of 10 min, an aortic cineangiogram was performed .
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Foerow-up . After the procedure, patients recovered in the
outpatient surgery ward . Four hours later an echocardio-
gram and chest radiograph were performed
. Cefazolin
(40 mg/kg) was administered intravenously 6 h after implan-
tation
. Subsequently, patients were eligible for discharge
from hospital
. Outpatient follow-up was at 6 weeks and 6
months postprocedure
. During each of these visits patients
762
	
MOORE ET AL .
CLOSURE OF SMALL PATENT DUCTUS BY SPRING COILS
underwent a physical examination, chest radiography and Table 1
. Patients With Successful Occlusion of Patent Ductus
Arteriosus by Coils
echocardiography .
Results
Of the 30 patients who underwent catheterization, 29 had
successful placement of one or two coils in the patent ductus
arteriosus
. The patient with unsuccessful coil placement is
described later
. There were no deaths or significant morbid-
ity in the 30 patients
. No patient received a blood transfu-
sion, and there were no arterial complications .
Of the 29 patients who had successful coil placement, 19
had audible grade 2 or 3 continuous heart murmurs
. Diag-
nosis in these patients was by examination and was con-
firmed by echocardiography . Ten patients were found to
have a patent ductus by echocardiography performed to
evaluate other cardiac abnormalities or nonspecific cardiac
murmurs
. In all 29 patients the minimal internal dimension
was :53 .0 mm, determined by measuring the narrowest width
of the color flow stream through the patent ductus arterio-
sus. During catheterization all patients had pulmonary artery
pressure in the normal range. Five patients with clinical
evidence of left ventricular volume overload (cardiomegaly
on chest radiograph and left ventricular hypertrophy on
electrocardiogram) had significantly increased pulmonary
blood flow (pulmonary/systemic flow ratio = 1 .4, 1 .4, 1 .4,
1 .5 and 1 .9 by oximetry). Twenty-four patients without
clinical evidence of left ventricular volume overload had
pulmonary blood flow :5 1 .3 times systemic flow by oximetric
determination . The smallest internal patent ductus arteriosus
dimensions ranged from 1 .0 to 3.0 mm (average 1 .7 mm)
(Table 1). By an angiographic classification of patent ductus
arteriosus (18), 19 patients had a patent ductus arteriosus
with the narrowest segment at the pulmonary insertion and a
cone-shaped aortic ampulla (type A) ; 5 patients had a short
patent ductus arteriosus with the narrowest segment at the
aortic end (type B) ; and S patients had a patent ductus
arteriosus with the narrowest segment at the pulmonary
insertion and an elongated cone-shaped aortic diverticula
(type E) . Twelve patients had patent ductus arteriosus
closure with the smallest coil (MWCE-384-3) . Fifteen pa-
tients had closure with the midsized coil (MWCE-38-5-5 or
X&A Two patients had two coils placed (MWCE-38-5-5
Q and MWCE-38-5-5 + MWCE 38-5-8) . Complete patent
ductus arteriosus occlusion was noted by aortography
10 min after the procedure in 18 patients (Fig . 2) . Color flow
imaging study 4 h after the procedure showed no residual
leak in these patients (Fig . 3) . In six patients postimplantan
tion angiograms showed small residual leaks, and complete
closure was demonstrated on color flow imaging studies
performed 4 h after implantation . Two patients initially had
residual leaks but had closure at the 6-week follow-up color
flow study . One patient with a residual leak at the initial and
6-week follow-up studies had no leak at the 6-month follow-
up color flow study (type B, internal dimension -1 .7 mm) .
Two patients (pending 6-month follow-up study) had persis-
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Classification of Krichenko el al . (18)
. PDA = patent ductus arteriosus
Pt = patient
. See text for PDA type definitions.
tent small leaks noted at their initial and 6-week follow-ul
color flow studies. These patients had extremely shor
ductus (type B) with smallest internal dimensions of 2 .1 ant
2.4 mm. All had one implanted coil with a loop diameter o
5 mm. As of the most recent follow-up visit, 27 of 29 patient
;
have no residual leak . Twenty-four of the 29 patients witl
patent ductus arteriosus occlusion had no additional inter
ventional catheterization procedure . Fluoroscopy time fo
these 24 patients averaged 12 .9 min (range 6.7 to 27) . Two o
these patients had coil retrieval after embolization of a coi
into the left pulmonary artery . Twenty-one procedures weri
performed during day admission (10 to 12 h in the hospital)
seven procedures required overnight admission (institutions
protocol at Walter Reed), and one procedure was performer
as part of a prolonged hospital stay for myocarditis .
Six-month follow-up evaluations have been performed ij
10 patients . Three of these patients have been reevaluated
>2 years after their procedure . Six-week postimplantatioi
evaluations were performed in nine additional patients . Nin,
patients have their long-term follow-up visits pending . On,
patient whose procedure was early in this series (Februar ;
1991) has been lost to follow-up. No complications hav ,
been noted in follow-up visits . There has been no fracture o
Pt
No . Age (mo)
Weight (kg)
PDA Minimal
Dimension (mm)
PDA
Type'
1 48 18 .0
1 .4 A
2 11 9 .5 1 .5 A
3 13 9 .5
1 .4 A
4 22 11 .5
1 .5 A
5 9 9 .9 1 .0 B
6 11 37 .0 1 .0 A
7 84 27 .2 1 .5
A
8 36 21 .0 2 .2
E
9 14 9 .0
1 .0 E
10 36
15.2 1 .9 A
11 60 16.8 1 .5 A
12 11 10.5 1t A
13 23 12.4
1 .7 B
14 16 9.3
2 .4 A
15 24 10 .6
0 A
16 7 8.2
1 .6 E
17 11 9.6 1 .7 A
18 36 14 .2 2 .1 B
19 144 42 .2 1 .2 A
20 Is 9 .4 2 .5
A
21 20 11 .9 2 .4
B
22 20 11 .8 2 .0
A
23 21 12 .1 2 .1 E
24 27 13 .0 1 .0 B
25 72 20 .1 1 .0 E
26 26 12 .9 1 .8 A
27 12 9.0 2 .2 A
28 120 35 .0 3 .0
A
29 66 25 .0 1 .7 A
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movement of the coils. Follow-up echocardiograms have
shown no turbulence in the descending thoracic aorta . Left
pulmonary artery stenosis has not been observed ; however,
color flow studies have detected turbulence in the proximal
left pulmonary artery in 10 of the 29 patients . The maximal
continuous wave Doppler velocity in the left pulmonary
artery in these 10 patients has been 1 .8 m/s . There has been
no clinical evidence of embolic phenotrena (systemic or
pulmonary) or of hemolysis .
One patient did not have successful implantation of coils
in the patent ductus arteriosus . This patient had a large
patent ductus arteriosus with a smallest dimension of
3.2 mm. Delivery of two coils was planned . The first coil
MOORE ET AL .
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Figure 2. Lateral aortograms showing the patent ductus arterics -is
before and after closure with occluding spring coils in Patients 8 (A
and R) and 10 (C and D).
(MCWE-38-5-5) was delivered uneventfully . During delivery
of the second coil (MCWE-38-5-5), both coils were pulled
into the pulmonary artery and migrated into the distal left
pulmonary artery system . Neither coil could be retrieved .
Further attempts to close the patent ductus arteriosus were
not undertaken . The patient recovered from the procedure
uneventfully and was discharged on the day of the proce-
dure. She did not develop signs of pulmonary infarction . Her
chest radiograph showed no localized infiltrates .
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Rpm 3. Two-dimensional (A mW 8) and color flow (C and D)
echocardiograms demonstrating a patent ductus arteriosus (PDA)
before (A mWC) and after (B and D) closure with an occluding spring
coil in Patient 8 . Ao = aorta, MPA = main pulmonary artery .
Discussion
Wthnim, of the patent ductus airtedosus. A
great deal of data with regard to percutaneous occlusion of
patent ductus arteriosus have accumulated during the past
decade (2-13) . To date, the Rashkind double-umbrella oc-
clusion system has been most completely studied and is
currently the most widely used system . Although learning
curves are minimized, and related complications such as
device embolization are rare, the system continues to have
two problems that may be addressed by coil occlusion . First,
the delivery system is larger than the patent ductus ai terio-
sus, including some that are hemodynamically significant . i n
many patients . The smaller Rashkind device uses an 8F
delivery system . In marginal cases, the system itself can act
as a patent ductus arteriosus dilator by being pushed across
a ductus whose smallest internal diameter is <8F (2 .5 mm) .
In certain situations, the complicated techniques described
by Benson and colleagues (14,15) (venous rendezvous of an
arterial exchange wire and angioplasty of the patent ductus
arteriosus) may be required . Moreover, some types of patens
ductus arteriosus cannot be occluded successfully by the
Benson technique (e .g ., residual patent ductus arteriosm
after surgical ligation) . The second problem is residual
patent ductus arteriosus or leaks after device implantation,
The long-term incidence of residual patent ouctus arteriosm
detected by color flow imaging studies is 21% to 34% (
months to I year after placement of a single RashkW
device. After 30 to 40 months (and in amenable cases, the
placement of a second device), the incidence of residua
leaks remains significant at 5 .2% to 8% (7,8,10,11).
Other systems currently used in human studies include
the buttoned device (12) and the Botallooccluder (13) . The
buttoned device requires a 7F delivery sheath . The Botal ,
looccluder requires a delivery sheath of at least l0F diame ,
ter. Neither system is capable of closing the very smal
patent ductus arteriosus with its standard delivery tech
niques. Many patients have been treated with the Botallo,
occluder, and the reported success rate is 95% . However
neither evaluation with color flow imaging nor long-tern
follow-up studies have been reported. To date, reports o
patent ductus arteriosus closure with the buttoned device an
too limited to determine the long-term rate of residual leaks
JACCVol. 2XNw3
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Risk of patent ductus arteriosus. Patent ductus arteriosus
in older infants, children and adults presents a hemodyna mic
burden with the risk of subacute bacterial endocarditis to
the patients . Regardless of the hemodynamic
significance
of the ductus, most authorities recommend closure soon
after the diagnosis is made (19,20) . "Silent" oatent ductus
arteriosus may be discovered incidentally or may be ob-
served as residual patent ductus arteriosus after placement
of an occlusion device . Although some investigators (16)
have argued that silent patent ductus arteriosus (whether
native or residual) need not be closed, it seems premature to
exclude silent patent ductus arteriosus from standard ther-
apy at this time .
Spring coils. Stainless steel coils have beets in clinical aye
since 1975 . Coil occlusion has been used in the treatment of
collateral arteries, vascular malformations, arteriovenous
fistula, surgically created aortopulmonary shunts and super-
Huous systemic and pulmonary venous connections (21-24) .
We (17) have previously studied a small group of patients
who underwent patent ductus arteriosus closure with coil
emboli (17) . This report describes the first significant series
of patients to undergo successful patent ductus arteriosus
closure with the use of stainless steel coils .
Coil occlusion of patent ductus arteriosus. Our study
demonstrates that the small native patent ductus arteriosus
can be occluded with available spring coils . We believe that
two factors determined from high resolution digital angiog-
raphy are important in definitive patient selection . These
factors are minimal internal dimension and configuration of
the patent ductus arteriosus . We successfully closed five
ducts >2.0 mm, and all except one were <_2 .5 trim. We
believe that with currently available coils, 2 .5 mm is the
upper limit of size for predictable complete closure . More-
over, our experience separates the ductus with a very short
aortic ampulla (type B) from the configurations with a
significant aortic ampulla (types A and E)
. Two of five
patients with a type B configuration have small residual
leaks. Thus, we think that type B ductus arteriosi should not
be considered for closure with the currently available coils
unless the minimal internal dimension is <1 .7 mm .
Finally, we speculate that the small residual patent ductus
arteriosus (after device implantation or surgical ligation) is
also amenable to occlusion with existing coils . The larger
patent ductus arteriosus may also be closed with coils,
especially if custom designs and more controlled delivery
systems are developed . Closure of the small type B, the
residual and the large patent ductus arteriosus with coils
requires further study .
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